Marcus, a major vaccine company, is also in the running for the Covid 19 vaccine

Marks, one of the largest vaccine companies in the world, has joined the race to find a vaccine for the corona virus.

The US company announced on Tuesday that it was working on two different approaches to finding effective vaccines.

Marks, an Austrian company, is buying Themis Bioscience, which is currently working on a measles vaccine for possible use of Code 19. Clinical trials are expected to begin in weeks.

The company's announcement comes after President Trump announced the availability of the vaccine "at the end of the year or soon after."

On the other hand, the US-based biotechnology firm Novax has announced that experiments have been started on humans in Australia for a possible corona virus vaccine.